{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:00:23Z","timestamp":1792123223121,"version":"4.4.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The current article highlights recent developments in the field of pediatric cutaneous mastocytosis. Mastocytosis is a spectrum of conditions that range from fleetingly benign to aggressively malignant. Through recognizing the natural progression of disease, the role of biomarkers and mutational analysis, treatment and risk of triggers, physicians can confidently stage, counsel and manage patients with pediatric cutaneous mastocytosis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Many lesions of cutaneous mastocytosis are chronic with some resolving around the mid-teenage years. KIT mutations are found in the majority of pediatric cutaneous mastocytosis but are not correlated with prognosis. Serum tryptase levels may be elevated in pediatric cutaneous mastocytosis patients without systemic mastocytosis. Pimecrolimus, omalizumab and tyrosine kinase inhibitors are effective treatment options. The low risk of NSAIDs and vaccinations has been characterized and epinephrine autoinjectors are rarely utilized in the pediatric cutaneous mastocytosis patient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>Pediatric cutaneous mastocytosis is a heterogeneous disease with good outcome overall. Organomegaly, elevated tryptase levels and the presence of KIT mutation in peripheral blood may aid in the decision to pursue bone marrow biopsy. The armamentarium of treatments has expanded and better understanding of the significance of triggers and vaccination safety allows the clinician to thoughtfully counsel and allay anxiety around pediatric cutaneous mastocytosis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mop.0000000000000922","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T13:00:35Z","timestamp":1594126835000},"page":"531-538","source":"Crossref","is-referenced-by-count":31,"title":["Pediatric mastocytosis"],"prefix":"10.1097","volume":"32","author":[{"given":"Sadaf H.","family":"Hussain","sequence":"first","affiliation":[{"name":"Department of Allergy and Immunology, Boston Children's Hospital"},{"name":"Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2016-09-731893","article-title":"Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts","volume":"129","author":"Valent","year":"2017","journal-title":"Blood"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.iac.2018.04.001","article-title":"Cutaneous mastocytosis in adults and children","volume":"38","author":"Matito","year":"2018","journal-title":"Immunol Allergy Clin North Am"},{"key":"R4-20230918","doi-asserted-by":"crossref","first-page":"AB89","DOI":"10.1016\/j.jaci.2017.12.287","article-title":"Serum tryptase levels in 114 pediatric patients with cutaneous mastocytosis","volume":"141","author":"Seth","year":"2018","journal-title":"J Allergy Clin Immune"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2174\/1573396315666181120163952","article-title":"Childhood solitary cutaneous mastocytoma: clinical manifestations, diagnosis, evaluation and management","volume":"15","author":"Leung","year":"2019","journal-title":"Curr Pediatr Rev"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"E306","DOI":"10.1111\/pde.13541","article-title":"Atypical maculopapular cutaneous mastocytosis showing a nevus spilus-like lesion","volume":"35","author":"Ahn","year":"2018","journal-title":"Pediatr Dermatol"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"AB109","DOI":"10.1016\/j.jaad.2018.05.464","article-title":"Diffuse cutaneous bullous mastocytosis: a rare case report and a review of the literature","volume":"79","author":"Hosting","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1525-1470.2010.01212.x","article-title":"Neonatal onset diffuse cutaneous mastocytosis: a case report and review of the literature","volume":"28","author":"Koga","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5114\/ada.2017.69308","article-title":"The role of serum tryptase in the diagnosis and monitoring of pediatric mastocytosis: a single center experience","volume":"34","author":"Lange","year":"2017","journal-title":"Postepy Dermatol Alergol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/pde.13801","article-title":"Management of a neonate with diffuse cutaneous mastocytosis: case report and literature review","volume":"36","author":"Jenkinson","year":"2019","journal-title":"Pediatr Dermatol"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jaci.2015.04.024","article-title":"Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis","volume":"136","author":"Carter","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/bjd.16795","article-title":"Pediatric mastocytosis: long-term follow up of 53 patients with whole sequencing of KIT. A prospective study","volume":"179","author":"Meni","year":"2018","journal-title":"Br J Dermatol"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/bjh.15624","article-title":"Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease","volume":"183","author":"Carter","year":"2018","journal-title":"Br J Haematol"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jaci.2015.04.024","article-title":"Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis","volume":"136","author":"Carter","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2500\/aap.2019.40.4201","article-title":"Pediatric cutaneous mastocytosis and c-KIT mutation screening","volume":"40","author":"Ertugrul","year":"2019","journal-title":"Allergy Asthma Proc"},{"key":"R17-20230918","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000316353","article-title":"Pimecrolimus induces apoptosis of mast cells in a murine model of cutaneous mastocytosis","volume":"153","author":"Ma","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/ced.13391","article-title":"Topical pimecrolimus for paediatric cutaneous mastocytosis","volume":"43","author":"Mashiah","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/ced.13408","article-title":"Effective management of severe cutaneous mastocytosis in young children with omalizumab (Xolair\u00ae)","volume":"43","author":"Hughes","year":"2018","journal-title":"Clin Exp Dermatol"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"541","DOI":"10.5114\/ada.2018.77605","article-title":"Cutaneous mastocytosis treatment: strategies, limitations and perspectives","volume":"35","author":"Czarny","year":"2018","journal-title":"Adv Dermatol Allergol"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1016\/j.jaip.2019.05.032","article-title":"Treatment of systemic mastocytosis in an infant with midostaurin","volume":"7","author":"Liu","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1080\/14656566.2019.1645121","article-title":"An evaluation of masitinib for treating systemic mastocytosis","volume":"20","author":"Laforgia","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"AB266","DOI":"10.1016\/j.jaci.2014.12.1809","article-title":"Adverse vaccine reactions in children with pediatric mastocytosis","volume":"135","author":"Clark","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R24-20230918","first-page":"409","article-title":"Neurocognitive dysfunction and anaphyklaxis in pediatric maculopapular cutaneous mastocytosis","volume":"8","author":"Gurnee","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"R26-20230918","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/pde.13636","article-title":"Patient perspectives: what is mastocytosis?","volume":"35","year":"2018","journal-title":"Pediatr Dermatol"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000922","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T02:28:34Z","timestamp":1695004114000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MOP.0000000000000922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000922","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}